General Information of the Cell Line
Cell Line ID
CL000743
Cell Line Name
CellSensor STAT6-bla RA-1
Synonyms
STAT6-bla RA-1
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_KS55
Tissue Information
Ascites
Disease
Burkitt lymphoma (NCIt: C2912)
Burkitt lymphoma (ORDO: Orphanet_543)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01659, Tyrosine-protein kinase JAK1
Compound ID Compound Name Compound Formula
CP0692982
[(1R,2R,4R,5S)-5-(3-Methyl-6-oxo-1,2,7-triaza-2,7-dihydroinden-4-yl)-2-norbornanyl]acetonitrile
   Show/Hide
C16H18N4O
 1
1
IC50 = 77 nM
   TI
   LI
   LO
   TS
CP0002393
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
   Show/Hide
C16H20N6O
 1
1
IC50 = 87 nM
   TI
   LI
   LO
   TS
CP0701646
rac-3-Methyl-4-[trans-4-[2-oxo-2-(3-phenylpyrrolidin-1-yl)-ethyl]cyclohexyl]-2,7-dihydropyrazolo[3,4-b]pyridin-6-one
   Show/Hide
C25H30N4O2
 1
1
IC50 = 110 nM
   TI
   LI
   LO
   TS
CP0812653
4-[trans-4-[2-(4,4-Dimethyl-1-piperidyl)-2-oxo-ethyl]-cyclohexyl]-3-methyl-2,7-dihydropyrazolo[3,4-b]pyridin-6-one
   Show/Hide
C22H32N4O2
 1
1
IC50 = 110 nM
   TI
   LI
   LO
   TS
CP0640933
ABROCITINIB
   Show/Hide
C14H21N5O2S
 1
1
IC50 = 180 nM
   TI
   LI
   LO
   TS
CP0712228
4-[trans-4-[2-(3-Benzylazetidin-1-yl)-2-oxo-ethyl]-cyclohexyl]-3-methyl-2,7-dihydropyrazolo[3,4-b]pyridin-6-one
   Show/Hide
C25H30N4O2
 1
1
IC50 = 250 nM
   TI
   LI
   LO
   TS
CP0701645
[trans-4-(3-Methyl-6-oxo-2,7-dihydropyrazolo[3,4-b]-pyridin-4-yl)cyclohexyl] (1S)-2,2-difluorocyclopropanecarboxylate
   Show/Hide
C17H19F2N3O3
 1
1
IC50 = 420 nM
   TI
   LI
   LO
   TS
CP0692981
[(1S,2S,4S,5R)-5-(3-Methyl-6-oxo-1,2,7-triaza-2,7-dihydroinden-4-yl)-2-norbornanyl]acetonitrile
   Show/Hide
C16H18N4O
 1
1
IC50 = 770 nM
   TI
   LI
   LO
   TS
CP0701648
rac-3-Methyl-4-[(1R*,2S*,4S*)-norbornan-2-yl]-2,7-dihydropyrazolo[3,4-b]pyridin-6-one
   Show/Hide
C14H17N3O
 1
1
IC50 = 850 nM
   TI
   LI
   LO
   TS
CP0701641
rac-4-(2-Bicyclo[2.2.2]octanyl)-3-methyl-2,7-dihydropyrazolo-[3,4-b]pyridin-6-one
   Show/Hide
C15H19N3O
 1
1
IC50 = 890 nM
   TI
   LI
   LO
   TS
CP0701647
rac-3-Methyl-4-[(1R*,2R*,4S*)-norbornan-2-yl]-2,7-dihydropyrazolo[3,4-b]pyridin-6-one
   Show/Hide
C14H17N3O
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0692984
2-[trans-4-(3-Methyl-6-oxo-2,7-dihydropyrazolo[3,4-b]-pyridin-4-yl)cyclohexyl]acetonitrile
   Show/Hide
C15H18N4O
 1
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0693222
3-[trans-4-(3-Methyl-6-oxo-2,7-dihydropyrazolo[3,4-b]-pyridin-4-yl)cyclohexyl]propanenitrile
   Show/Hide
C16H20N4O
 1
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0768026
[(1S,2R,4S,5R)-5-(3-Methyl-6-oxo-1,2,7-triaza-2,7-dihydroinden-4-yl)-2-norbornanyl]acetonitrile
   Show/Hide
C16H18N4O
 1
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0692983
rac-3-Methyl-4-[(1S*,2R*)-2-methylcyclohexyl]-2,7-dihydropyrazolo[3,4-b]pyridin-6-one
   Show/Hide
C14H19N3O
 1
1
IC50 = 1300 nM
   TI
   LI
   LO
   TS
CP0692980
(1S)-2,2-Difluoro-N-[trans-4-(3-methyl-6-oxo-2,7-dihydropyrazolo[3,4-b]pyridin-4-yl)cyclohexyl]-cyclopropanecarboxamide
   Show/Hide
C17H20F2N4O2
 1
1
IC50 = 1700 nM
   TI
   LI
   LO
   TS
CP0162853
4-cyclohexyl-3-cyclopropyl-2,7-dihydropyrazolo[3,4-b]pyridin-6-one
   Show/Hide
C15H19N3O
 1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0207734
4-cyclohexyl-3-ethyl-2,7-dihydropyrazolo[3,4-b]pyridin-6-one
   Show/Hide
C14H19N3O
 1
1
IC50 = 2500 nM
   TI
   LI
   LO
   TS
CP0701643
[(1R,2S,4R,5S)-5-(3-Methyl-6-oxo-1,2,7-triaza-2,7-dihydroinden-4-yl)-2-norbornanyl]acetonitrile
   Show/Hide
C16H18N4O
 1
1
IC50 = 2700 nM
   TI
   LI
   LO
   TS
CP0812651
1-Cyclobutyl-N-[trans-4-(3-methyl-6-oxo-2,7-dihydropyrazolo[3,4-b]pyridin-4-yl)cyclohexyl]-methanesulfonamide
   Show/Hide
C18H26N4O3S
 1
1
IC50 = 3200 nM
   TI
   LI
   LO
   TS
CP0124474
4-(cyclobutylmethyl)-3-methyl-2,7-dihydropyrazolo[3,4-b]pyridin-6-one
   Show/Hide
C12H15N3O
 1
1
IC50 = 3400 nM
   TI
   LI
   LO
   TS
CP0330677
4-cyclohexyl-3-methyl-2,7-dihydropyrazolo[3,4-b]pyridin-6-one
   Show/Hide
C13H17N3O
 1
1
IC50 = 3700 nM
   TI
   LI
   LO
   TS
CP0207730
4-cyclopentyl-3-methyl-2,7-dihydropyrazolo[3,4-b]pyridin-6-one
   Show/Hide
C12H15N3O
 1
1
IC50 = 4300 nM
   TI
   LI
   LO
   TS
CP0162855
4-cyclohexyl-5-(hydroxymethyl)-3-methyl-2,7-dihydropyrazolo[3,4-b]pyridin-6-one
   Show/Hide
C14H19N3O2
 1
1
IC50 = 4800 nM
   TI
   LI
   LO
   TS
CP0356130
4-cyclohexyl-5-(2-hydroxyethyl)-3-methyl-2,7-dihydropyrazolo[3,4-b]pyridin-6-one
   Show/Hide
C15H21N3O2
 1
1
IC50 = 8500 nM
   TI
   LI
   LO
   TS
CP0701644
N-[trans-4-(3-Methyl-6-oxo-2,7-dihydropyrazolo[3,4-b]-pyridin-4-yl)cyclohexyl]cyclopentanecarboxamide
   Show/Hide
C19H26N4O2
 1
1
IC50 = 9100 nM
   TI
   LI
   LO
   TS
CP0735624
N-[trans-4-(3-Methyl-6-oxo-2,7-dihydropyrazolo[3,4-b]-pyridin-4-yl)cyclohexyl]cyclopropanecarboxamide
   Show/Hide
C17H22N4O2
 1
1
IC50 > 14000 nM
   TI
   LI
   LO
   TS
CP0812652
rac-1-[2-[trans-4-(3-Methyl-6-oxo-2,7-dihydropyrazolo[3,4-b]-pyridin-4-yl)cyclohexyl]acetyl]pyrrolidine-3-carbonitrile
   Show/Hide
C20H25N5O2
 1
1
IC50 = 14000 nM
   TI
   LI
   LO
   TS
CP0330676
4-cyclohexyl-3-methyl-6-oxo-2,7-dihydropyrazolo[3,4-b]pyridine-5-carbonitrile
   Show/Hide
C14H16N4O
 1
1
IC50 = 20000 nM
   TI
   LI
   LO
   TS
CP0812656
4-(4-trans-Hydroxycyclohexyl)-3-methyl-2,7-dihydropyrazolo[3,4-b]pyridin-6-one
   Show/Hide
C13H17N3O2
 1
1
IC50 = 20000 nM
   TI
   LI
   LO
   TS
CP0701642
1-[2-[trans-4-(3-Methyl-6-oxo-2,7-dihydropyrazolo[3,4-b]-pyridin-4-yl)cyclohexyl]acetyl]azetidine-3-carbonitrile
   Show/Hide
C19H23N5O2
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0692985
4-(4-trans-Aminocyclohexyl)-3-methyl-2,7-dihydropyrazolo[3,4-b]pyridin-6-one
   Show/Hide
C13H18N4O
 1
1
IC50 > 40000 nM
   TI
   LI
   LO
   TS
CP0712223
N-Cyclopropyl-trans-4-(3-methyl-6-oxo-2,7-dihydropyrazolo[3,4-b]pyridin-4-yl)cyclohexanecarboxamide
   Show/Hide
C17H22N4O2
 1
1
IC50 > 40000 nM
   TI
   LI
   LO
   TS
CP0768025
(1R)-2,2-Difluoro-N-[trans-4-(3-methyl-6-oxo-2,7-dihydropyrazolo[3,4-b]pyridin-4-yl)cyclohexyl]-cyclopropanecarboxamide
   Show/Hide
C17H20F2N4O2
 1
1
IC50 > 40000 nM
   TI
   LI
   LO
   TS
CP0207733
4-cyclohexyl-1,7-dihydropyrazolo[3,4-b]pyridin-6-one
   Show/Hide
C12H15N3O
 1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0330675
3-methyl-4-phenyl-2,7-dihydropyrazolo[3,4-b]pyridin-6-one
   Show/Hide
C13H11N3O
 1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Ascites)
Cell Line Name Organism Disease
PEO1 Homo sapiens (Human) BRCA2-associated hereditary breast and ovarian cancer syndrome
MAST Homo sapiens (Human) Breast carcinoma
Ramos Homo sapiens (Human) Burkitt lymphoma
CA46 Homo sapiens (Human) Burkitt lymphoma
NCI-H716 Homo sapiens (Human) Cecum adenocarcinoma
COLO 205 Homo sapiens (Human) Colon adenocarcinoma
COLO 201 Homo sapiens (Human) Colon adenocarcinoma
DiFi Homo sapiens (Human) Colorectal carcinoma
U-2932 Homo sapiens (Human) Diffuse large B-cell lymphoma activated B-cell type
DB Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
HEC-50B Homo sapiens (Human) Endometrial adenocarcinoma
SNU-5 Homo sapiens (Human) Gastric adenocarcinoma
SNU-16 Homo sapiens (Human) Gastric adenocarcinoma
SNU-620 Homo sapiens (Human) Gastric adenocarcinoma
SNU-638 Homo sapiens (Human) Gastric adenocarcinoma
SNU-668 Homo sapiens (Human) Gastric signet ring cell adenocarcinoma
OVCAR-3 Homo sapiens (Human) High grade ovarian serous adenocarcinoma
OVCAR-5 Homo sapiens (Human) High grade ovarian serous adenocarcinoma
COV318 Homo sapiens (Human) High grade ovarian serous adenocarcinoma
ZR-75-1 Homo sapiens (Human) Invasive breast carcinoma of no special type
SK-HEP-1 Homo sapiens (Human) Liver and intrahepatic bile duct epithelial neoplasm
OV-90 Homo sapiens (Human) Ovarian adenocarcinoma
LK2 Homo sapiens (Human) Ovarian carcinoma
RMG-I Homo sapiens (Human) Ovarian clear cell adenocarcinoma
PA-1 Homo sapiens (Human) Ovarian mixed germ cell tumor
SK-OV-3 Homo sapiens (Human) Ovarian serous cystadenocarcinoma
SKOV3/TR Homo sapiens (Human) Ovarian serous cystadenocarcinoma
AsPC-1 Homo sapiens (Human) Pancreatic ductal adenocarcinoma
HEC Homo sapiens (Human) Peritoneal malignant mesothelioma
Ehrlich-Lettre ascites strain E Mus musculus (Mouse) Malignant neoplasms of the mouse mammary gland
RAW 264.7 Mus musculus (Mouse) Mouse leukemia
L1210 Mus musculus (Mouse) Mouse leukemia
L1210/R81 Mus musculus (Mouse) Mouse leukemia
RAW-Lucia ISG Mus musculus (Mouse) Mouse leukemia
RAW-Lucia ISG-KO-STING Mus musculus (Mouse) Mouse leukemia
RAW 264 Mus musculus (Mouse) Mouse leukemia
J774 Mus musculus (Mouse) Mouse reticulum cell sarcoma
J774A1 Mus musculus (Mouse) Mouse reticulum cell sarcoma
HTC Rattus norvegicus (Rat) Rat hepatocellular carcinoma